{"name":"Repligen Corporation","slug":"repligen-corporation","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxQMThpcW0xbkh6bzhsTEE4OFU2M24ydWppR0ZKd2FwRUVLZHVzNUlWMlc0Snk0UmtRV3BvRDd1eTRMTmRwRVI5NHpkV0RaVmg0bTFNbXJlX1FjcW5qYU1DREpwY05odDlNMDQ5OEtOc2tPLWJkQUw5djVCbXIwU1NKalNXRllvcVRaZ2xfSA?oc=5","date":"2026-03-06","type":"pipeline","source":"Yahoo Finance","summary":"AMN Healthcare Services, RadNet, Evolent Health, Repligen, and Amphastar Pharmaceuticals Stocks Trade Down, What You Need To Know - Yahoo Finance","headline":"AMN Healthcare Services, RadNet, Evolent Health, Repligen, and Amphastar Pharmaceuticals Stocks Trade Down, What You Nee","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxPT3FTMzNzd3d2UXI0VGlCTDY5aTVvUDFDc1ZLazFfNS1JWHptTGxvZUFJZ1JiYTVFdnQwMnpUWUQyN1VIcm92V0NpLUNnenhZTm5YMXI2N1ZSLXBHc3c0aFZVcXhPY3ZKTW5zZEduNHhVZDIxb0U4NVo5el9JenNhVnVtNnhxZWJEbG5FbXFTRVBpSmlMYk5vLU9XT0xBTVpMTEl2LXg4ODdsLXllUkdLZ0EyemoxOVVFQTVJeGxzcC1xVko2MGc?oc=5","date":"2026-02-24","type":"earnings","source":"Investing.com","summary":"Earnings call transcript: Repligen Q4 2025 earnings surpass expectations - Investing.com","headline":"Earnings call transcript: Repligen Q4 2025 earnings surpass expectations","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxPWExaN2I1VzJXWGI5U2g1eXpoOGdUZjVCWEw3N0FOM1I2c0U3a1J3TXVBWGdkakI0MTFfQjhrYlpjdUNGWUIxMlBTdHo3SXNoQkFnTTRERGdhY0RpRk5uV3NBODZGQVVlTGVPSlhlZmF6OTZRSjZFaGtRM19tNFFVYnRNeEh4aVJUUkRZZXhCZDVYMUlSdTk4R3pNcw?oc=5","date":"2026-02-22","type":"earnings","source":"finviz.com","summary":"Repligen (RGEN) To Report Earnings Tomorrow: Here Is What To Expect - finviz.com","headline":"Repligen (RGEN) To Report Earnings Tomorrow: Here Is What To Expect","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxOejI2ZElzQUctQ2YxWEJPNXRkaURtVHFNeGRyMy00VzkwUDMyUl9lMS0taFJ4UjFBQXFKTVl3dk9xT1BDX2RWOXJvQTZhdGZlWVRlTGZzOWR5U0hsdEM0Sk80QnhieUpyaHd4UHJCUmpic25MVFJEWnJRdEU2S2cyWFAyVkVRQmppdlpkUl90dWNHS0NjejVzUURqdGtVR2RXWk9kRXZjLUs?oc=5","date":"2025-11-14","type":"pipeline","source":"Seeking Alpha","summary":"Repligen Stock: Rare Growth In The Biopharma Supplies Industry (NASDAQ:RGEN) - Seeking Alpha","headline":"Repligen Stock: Rare Growth In The Biopharma Supplies Industry (NASDAQ:RGEN)","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-10-31","type":"pipeline","source":"simplywall.st","summary":"Repligen Corporation Just Beat EPS By 18%: Here's What Analysts Think Will Happen Next - simplywall.st","headline":"Repligen Corporation Just Beat EPS By 18%: Here's What Analysts Think Will Happen Next","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxOZVgyS2xtQU5fTmpMTm9qc1ZvYzFJZUFxckZvZHhiTm1NSzNhRjBOQ3NET1RncnZEOEE2eXlNQ0RNeFVmYXRCRHo2VXpRY1VWTjZTaWVpQU1NX2NGc1VSZ0c3Tl9qZHNFb3hOcFkxMHF6Q2Z0aGxsVjdKZDlzb28xZTY5M1VXTmN2dHV3Y0NBSWV2ZC1tS0ZjYl9UaVhfWkNhWlNfWXFUeU8?oc=5","date":"2025-10-26","type":"earnings","source":"TradingView","summary":"Repligen Earnings: What To Look For From RGEN - TradingView","headline":"Repligen Earnings: What To Look For From RGEN","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-10-04","type":"pipeline","source":"simplywall.st","summary":"Why Investors Shouldn't Be Surprised By Repligen Corporation's (NASDAQ:RGEN) 28% Share Price Surge - simplywall.st","headline":"Why Investors Shouldn't Be Surprised By Repligen Corporation's (NASDAQ:RGEN) 28% Share Price Surge","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxOWTVWSmN6OHM4d1lGUUxEUmYzeHpKOWpwaFRGb09Fd2NhQm5DdUItdThCbHJJVjBYTV9iclhpb0ZPckJ2dVpuUEI5ekZIcW9MRFRNZXpPLVVpTHNqcm1MeUZGWDFEaVVHYzhLRGhZeEdnM2Q0TzBWR2VwZTE2Z0c5VDZkZ3NvUE5RU0t5X3l1cWl1dEtyUnI2SHp5NGZ4Tmh0bERpVE1GaHVUUGRwaU1Nc184UzhLaTg3REh2bnZB?oc=5","date":"2025-07-09","type":"deal","source":"Contract Pharma","summary":"Univercells, Repligen Partner to Integrate Real-Time Monitoring Capabilities - Contract Pharma","headline":"Univercells, Repligen Partner to Integrate Real-Time Monitoring Capabilities","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxOQ1FVQTlTNHdSYjZicW4tQVBYb2F3M1lYbEtYbF93U2lrVzZZaDhkYndkbk9obzJaSzY4NFBmckFsWGRrMFZkcFltTVg4Z1cyb1Qyb0dxU0ZsaERuOWVwa3N2d1Z4RlRVOEFMbi1EdUdMTXZkMm5PRUIwYl8wZWRIWGlvWkdwcnpMcUZhYlg3aDF1bzFOLXc?oc=5","date":"2025-05-01","type":"earnings","source":"IndexBox","summary":"Repligen Corporation Exceeds Expectations with 10.4% Sales Growth in Q1 2025 - News and Statistics - IndexBox","headline":"Repligen Corporation Exceeds Expectations with 10.4% Sales Growth in Q1 2025 - News and Statistics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxQM2RWeXdUMlY1bVF5SHQ0Tk5yajgtZXk2RkJ3RjVJR1VzSkVJVm16cndyTHJpQ2c1d2gxaEJEUVhjZTBNOEtSTVhtMWNBOGkySEpjRjZDM2ZEVFBSUjFBeGVESk9CUnhRZVdfdXpDQmhvWXhhVXVyQ1FmQWVrRWdqQ1daUDRTa1Ywb2hlWkZTeWp6QUw0TFM5RFpJVnNDemRPYlNPS19qZ0o3dw?oc=5","date":"2025-03-04","type":"deal","source":"Contract Pharma","summary":"Repligen Acquires 908 Devices’ Bioprocess Analytics Portfolio - Contract Pharma","headline":"Repligen Acquires 908 Devices’ Bioprocess Analytics Portfolio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxQWm91V1h6MFdOd2ZhR3djSzhnQnRNcG9KUm5WUkdLZmRyRHgwVWdDWlRuaVNxZEZzUkZmX3ptMkdORUVRQXVPSWZJVW9WZjRid2drZHVtX1B5MEFNRzV3YjFsVktPYWI0RkI0RFd1M1ZFTFlZMTlnM2ZSRWZZUm95eldRbEpaSHpUOVRiSW1tSzlOc0p3Nl90NEUxc0tDb1B1djZDeFVGMnN2VUU3VDY4UEJHcEtvcDN5QWc?oc=5","date":"2023-09-01","type":"pipeline","source":"Barron's","summary":"Drug Developer Stocks Are Risky. Why a Picks-and-Shovels Approach Makes Sense. - Barron's","headline":"Drug Developer Stocks Are Risky. Why a Picks-and-Shovels Approach Makes Sense. - Barron's","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPQklhaE9DYUM3bDMybDl2UG9jVlFYWGhWdnA4U2c0cDh6R3B4NmIwYnpTX3o0UkxfV1RxbklQQ3FZc21qSW0yOW1MT0JSY2xZWTdSRDlCeGM4dzRxd1lhbC1Ta05VNndCMXRTalJsR3I0bG9hVXRxRjlCd1Z2OXJLU2FvLXctSmRfeU8yMHdJVFlvUjJQSkxldGROZEJtWENPRS16dERB?oc=5","date":"2023-08-22","type":"pipeline","source":"PharmTech.com","summary":"Sartorius and Repligen Launch Upstream Processing Intensification System - PharmTech.com","headline":"Sartorius and Repligen Launch Upstream Processing Intensification System","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}